US FDA panel to review expanded use of Merck AstraZeneca's cancer drug https://ift.tt/Y5kcrpM

The companies' are seeking approval of the drug Lynparza in combination with other medications - biraterone and prednisone or prednisolone -for the treatment of a type of treatment-resistant prostate cancer in adult patients.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/pGwOAxU
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.